Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongyang Huoxue Decoction for sick sinus syndrome
ChiCTR1800018464Phase 2Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Tongyang Huoxue Decoction and theophylline in sick sinus syndrome (SSS) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Holter total effective rate. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
Tongyang Huoxue Decoctiontheophylline
03
Conditions
sick sinus syndrome (SSS)
Beyond the preview
Go deeper on ChiCTR1800018464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018464.